PolyPid (PYPD) is trading up at $5.20 (+0.19%), as of the latest quote. It operates in the Health Care sector.
| FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Operating income | −$18.4M | −$18.6M | −$26.3M | −$43.1M | −$38.9M | −$22.9M | −$28.0M | −$33.0M |
| Net income | $5.92M | −$6.91M | −$36.9M | −$42.6M | −$39.6M | −$23.9M | −$29.0M | −$34.2M |
| EPS (diluted) | $25.80 | $710.70 | $134.40 | $68.27 | $61.09 | $16.93 | $4.91 | $2.09 |
| Balance sheet | ||||||||
| Cash and equivalents | $7.77M | $3.92M | $4.32M | $9.82M | $8.55M | $5.31M | $15.6M | $6.40M |
| Total assets | — | $33.8M | $75.8M | $44.2M | $26.0M | $15.4M | $25.2M | $22.3M |
| Total liabilities | — | $121.4M | $3.07M | $8.28M | $20.1M | $17.5M | $17.5M | $11.3M |
| Long-term debt | — | — | — | — | $7.57M | $6.38M | $634.0K | — |
| Shareholders' equity | −$81.7M | −$87.6M | $72.8M | $36.0M | $5.83M | −$2.10M | $7.68M | $11.0M |
| Cash flow | ||||||||
| Operating cash flow | −$16.7M | −$17.4M | −$21.6M | −$32.4M | −$34.3M | −$17.2M | −$22.0M | −$27.9M |
| Capital expenditure | $3.07M | $879.0K | $781.0K | $2.65M | $1.77M | $196.0K | $76.0K | $210.0K |
| Free cash flow | −$19.8M | −$18.2M | −$22.4M | −$35.0M | −$36.1M | −$17.4M | −$22.0M | −$28.1M |
| Q2 FY23Jun 2023 | Q4 FY23Dec 2023 | Q1 FY24†Mar 2024 | Q2 FY24Jun 2024 | Q4 FY24Dec 2024 | Q1 FY25†Mar 2025 | Q2 FY25Jun 2025 | Q4 FY25Dec 2025 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Operating income | −$5.82M | — | −$6.30M | −$6.12M | — | −$7.58M | −$9.40M | — |
| Net income | −$5.84M | — | −$6.45M | −$6.29M | — | −$8.27M | −$9.98M | — |
| EPS (diluted) | $3.95 | — | $1.37 | $1.25 | — | $0.70 | $0.78 | — |
| Balance sheet | ||||||||
| Cash and equivalents | $3.40M | $5.31M | — | $3.08M | $15.6M | — | $17.4M | $6.40M |
| Total assets | $26.3M | $15.4M | — | $19.5M | $25.2M | — | $37.7M | $22.3M |
| Total liabilities | $17.9M | $17.5M | — | $17.9M | $17.5M | — | $17.2M | $11.3M |
| Long-term debt | $8.54M | $6.38M | — | $3.13M | $634.0K | — | — | — |
| Shareholders' equity | $8.35M | −$2.10M | $7.14M | $1.60M | $7.68M | $86.0K | $20.5M | $11.0M |
From PolyPid's 20-F and 6-K filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Per-share figures are per ordinary share, which is not always the share traded in the US: an ADS can stand for several, or for part of one. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
No recent news mentioning PolyPid in our feed yet.